Drugs: Pressemitteilungen - Kategorie - Seite 25

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc.

OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwired) -- 03/06/15 -- On March 4, 2015, a class action lawsuit was filed in the United States District Court for the Northern District of Illinois against Akorn, Inc. (NAS ...

Flamel Technologies to Present at Two Upcoming Investor Conferences

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 03/05/15 -- Flamel Technologies S.A. (NASDAQ: FLML) today announced that the Company will be presenting at two upcoming investor conferences.Steve Lisi, the Company&# ...

Taconic Biosciences Support Helps to Advance Rare Disease Research

HUDSON, NY: Rare Genomics Institute Launches 2015 Be HEARD Challenge With Taconic as a Sponsor ...

Theravance Biopharma to Report Fourth Quarter 2014 Financial Results on March 10, 2015

GEORGE TOWN, GRAND CAYMAN: GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 03/03/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release ...

Serenus Biotherapeutics Enters Equity Purchase and Acquisition Agreement With Ireland-Based Global Life Sciences Company

SAN FRANCISCO, CA and JOHANNESBURG, SOUTH AFRICA: Malin Corporation plc to Invest up to $43 Million for up to a 76 Percent Stake in Specialty Pharmaceutical Focused on Africa ...

Insys Therapeutics Reports Fourth Quarter and Year End 2014 Results

PHOENIX, AZ: Record Quarterly Revenue of $66.5 Million Driven by Continued Growth in Subsys Net Revenue ...

Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial and Operational Results

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/03/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), today reported financial results for the fourth quarter and year ended December 31, 2014. Reven ...

Titan Pharmaceuticals to Present at 27th Annual ROTH Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/03/15 -- (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing i ...

SuperSonic Imagine to Present at the Cowen and Company 35th Annual Health Care Conference on March 4, 2015

AIX-EN-PROVENCE, FRANCE: AIX-EN-PROVENCE, FRANCE -- (Marketwired) -- 02/27/15 -- SuperSonic Imagine (EURONEXT PARIS: SSI) (Euronext: SSI, FR0010526814), the highly innovative medical imaging company that invented ShearWaveâ„ ...

Insys Therapeutics Announces Its Pharmaceutical Cannabidiol Received Fast Track Designation From FDA for the Treatment of Dravet Syndrome

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 02/26/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track designation to ...

Theravance to Present at the Cowen Healthcare Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/25/15 -- Theravance, Inc. (NASDAQ: THRX) announced today that Michael W. Aguiar, Theravance's President and Chief Executive Officer, is scheduled t ...

Marina Biotech Provides 2014 Year-End Financials and Update

BOTHELL, WA: Company Expands Global Intellectual Property Estate to Over 140 Issued and Allowed Patents ...

SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2014 on March 11th

FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 02/25/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the fourth quarter and full year 2014 on We ...

Regen BioPharma Inc. Announces Preferred Stock Dividend

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 02/24/15 -- Regen BioPharma Inc. (OTCBB: RGBP) announced today that its Board of Directors has declared a stock dividend to common shareholders of record as of March ...

Theravance Biopharma Enrolls First Patient in Phase 3 Registrational Study of Telavancin in Staphylococcus Aureus Bacteremia

GEORGE TOWN, GRAND CAYMAN: Trial Designed to Support Regulatory Filing; Potential to Expand Label for VIBATIV(R) (telavancin) to Third Difficult-to-Treat, Gram-Positive Infection Type ...

VANC Pharmaceuticals Announces Low Cost Alternative Approval of 14 Products From British Columbia Ministry of Health

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/24/15 -- VANC Pharmaceuticals Inc. (TSX VENTURE: NPH)(OTCQB: NUVPF) ("VANC" or the "Company"), a pharmaceutical company focused ...

Insys Therapeutics In-Licenses Novel Mast Cell Therapy for Chronic Pelvic Pain

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 02/24/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) has entered into an exclusive sub-license agreement with Gold Coast Therapeutics to develop a unique combination of ...

Theravance, Inc. Announces Cash Dividend of $0.25 per Share Payable to Stockholders of Record as of March 12, 2015

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/23/15 -- Theravance, Inc. (NASDAQ: THRX) ("Theravance") today announced that the company's Board of Directors has declared a $0.25 per sh ...

VANC Pharmaceuticals Announces Supplier Letter of Intent With a Western Canadian Pharmacy Chain

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/20/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...


Seite 25 von 66:  « ..  24 25 26  27  28  29  30  31  32  33  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z